Results 21 to 30 of about 261,124 (307)

Improving treatment for acute ischemic stroke—Clot busting innovation in the pipeline

open access: yesFrontiers in Medical Technology, 2022
Acute ischemic stroke is a consequence of disrupted blood flow to the brain, caused by thrombosis—the pathological formation of occlusive clots within blood vessels, which can embolize distally to downstream tissues and microvasculature.
Joanna Shu Ting Liu   +6 more
doaj   +1 more source

Anticoagulants [PDF]

open access: yesBritish Medical Bulletin, 2000
Anticoagulation is a treatment with significant and life threatening complications requiring that the balance of risk and benefit be individually assessed in each patient. The risks are greater in the elderly and those with hypertension, falls and gastrointestinal disease.
openaire   +2 more sources

Utility and safety of nafamostat mesilate for anticoagulation in dogs

open access: yesVeterinary Medicine and Science, 2023
Background Surgical interventions are recommended for cases of advanced mitral regurgitation, however, limited facilities are available. The most prominent complication in such procedures is heparin‐derived bleeding.
Noriko Isayama   +4 more
doaj   +1 more source

Spontaneous Celiac Artery Dissection with Splenic Infarction: A Report of Two Cases

open access: yesVascular Specialist International, 2023
Spontaneous isolated celiac artery dissection (SICAD) is a rare condition that is characterized by sudden onset abdominal pain, typically occurring in middle-aged men. Although its clinical course is mostly benign, it may progress to true lumen occlusion.
Suh Min Kim, Hyunmin Ko
doaj   +1 more source

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

open access: yesAmerican journal of hematology/oncology, 2019
Two specific reversal agents for direct oral anticoagulants (DOACs) have been approved in the United States: idarucizumab for dabigatran reversal and andexanet alfa for apixaban and rivaroxaban reversal.
A. Cuker   +7 more
semanticscholar   +1 more source

Anticoagulants [PDF]

open access: yesJournal of Pharmacy and Pharmacology, 1949
Abstract The processes that underly the clotting of blood are still far from adequately understood, in spite of the many facts uncovered by generations of patient investigators. The classical scheme associated with the name of Morawitz1, although neither complete nor universally accepted, is still useful as a summary of the main events ...
openaire   +2 more sources

Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal Bleeding

open access: yesБезопасность и риск фармакотерапии, 2019
New oral  anticoagulants are  effective for  the  prevention of thromboembolic complications in patients with atrial fibrillation, or after orthopedic surgery.
A. P. Pereverzev   +3 more
doaj   +1 more source

Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy

open access: yesLife, 2023
Optimizing the anticoagulation therapy is of pivotal importance in patients with a malignant tumor, as venous thromboembolism (VTE) has become the second-leading cause of death in this population.
Vincenzo Russo   +10 more
doaj   +1 more source

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

open access: yesThe Lancet Haematology, 2019
BACKGROUND Treatment of venous thromboembolism in children is based on data obtained in adults with little direct documentation of its efficacy and safety in children.
C. Male   +38 more
semanticscholar   +1 more source

Abnormal Prothrombin (PIVKA-II) Expression in Canine Tissues as an Indicator of Anticoagulant Poisoning

open access: yesAnimals, 2021
PIVKA-II is an aberrant form of vitamin K that has been demonstrated to be increased in human coagulation disorders and in some neoplastic diseases.
Lorella Maniscalco   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy